Home
Products
Learn
About
Pricing
Log In
EOF
Asset Logo

Ecofibre Limited

🇦🇺 ASX

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

N/A
Annual Growth

5 years average annual capital growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

7
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Ecofibre Ltd. provides hemp products in the United States and Australia. The company is headquartered in Sydney, New South Wales. The company went IPO on 2019-03-29. The firm operates three vertically integrated businesses focused on growth in natural health care, plant-based foods, and sustainable product solutions. The firm has three segments: Ananda Food, Ananda Health and Hemp Black. Ananda Food segment owns collections of hemp seed genetics. The company is a manufacturer of hemp food products in Australia, including oil, seed and proteins. Ananda Health segment is a United States manufacturer of hemp-based nutraceuticals for the professional market. The company produces cannabidiol (CBD) products for human and pet consumption and topical health and beauty products. Its products are focused on conditions, including sleep, pain, anxiety, endometriosis and gynecological diseases. Hemp Black segment is an industrial business focused on textiles and bioplastics, with specialist capabilities in yarn extrusion, knitting and polymer compounding. The company uses hemp-based composite technology.

📈 Performance

Price History

-80.00%

1M

All Time

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.20

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in EOF

7

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

N/A

💵 Average investment amount

N/A

Last time a customer invested in EOF

1042 days
EOF investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

38%

50k - 100k

38%

Less than 50k

25%
👶 Age of investors

18 - 25

14%

26 - 34

71%

35 - 90

14%
🙋 Legal gender of investors

Female

43%

Male

57%

Pearlers who invest in EOF also invest in...

Vanguard Australian Shares Index Etf

VAS

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

📊 Share price

$90.18 AUD

NULL AUSTRALIA

NULL BETA

Find Out More

Incannex Healthcare Ltd. is a clinical stage pharmaceutical development company, which engages in the research and development associated with medicinal cannabinoid and psychedelic pharmaceutical products and therapies. The company is headquartered in Melbourne, Victoria. The company went IPO on 2007-05-23. The firm is engaged in the research and development associated with medicinal cannabinoid and psychedelic pharmaceutical products and therapies. The firm targets five indications: obstructive sleep apnea (OSA), traumatic brain injury and concussion (TBI), rheumatoid arthritis (RA), inflammatory bowel disease (IBD) and inflammatory lung conditions. Its drug candidates include IHL-42X, IHL-216A, Psilocybin-assisted psychotherapy for general anxiety disorder (Psi-GAD) and IHL-675A. Its IHL-42X is a cannabinoid combination product for treatment of OSA. Its IHL-675A comprises a combination of hydroxychloroquine and CBD for prevention and treatment of inflammatory lung conditions, rheumatoid arthritis and inflammatory bowel diseases. IHL-216A is a cannabinoid combination product for the treatment of TBI. The company is investigating the use of psilocybin-assisted psychotherapy to treat GAD.

📊 Share price

$0.12 AUD

Little Green Pharma Ltd. produces medicinal cannabis products for sale to Australian patients. The company is headquartered in Perth, Western Australia. The company went IPO on 2020-02-20. The firm has two global production sites for the manufacture of its own-branded and white-label ranges of Good Manufacturing Practice (GMP)-grade medicinal cannabis products, being a 21,500 square meters cultivation and 4,000 square meters GMP manufacturing facility capable of producing over 30 tons of medicinal cannabis biomass per annum located in Denmark (EU) and an indoor cultivation and manufacturing facility located in Western Australia capable of producing three tons of medicinal cannabis biomass per annum. The firm focuses on patient access in the global medicinal cannabis market and is actively engaged in promoting education and outreach programs, as well as participating in clinical investigations and research projects to develop new delivery systems.

📊 Share price

$0.17 AUD

Cann Group Ltd. operates research and development and cultivation facilities to grow medicinal cannabis. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-05-04. The principal activities of the Company include the cultivation of medicinal cannabis for both medicinal and research purposes pursuant to the licenses and permits issued to the group, the development and manufacture (via third party arrangements) of finished product formulations, and the pursuit and execution of various supply agreements with third parties. The firm supplies a range of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, to customers in Australia and around the world. The company also owns Satipharm and its patent-protected capsule technology. The firm's research, cultivation and good manufacturing practices (GMP) manufacturing facilities are located in Melbourne, and a cultivation and GMP manufacturing facility is near Mildura, Victoria.

📊 Share price

$0.17 AUD

Adore Beauty Group Ltd. operates as a marketing and e-commerce retail online beauty platform. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-10-23. The firm is an integrated content, marketing and electronic commerce retail platform that partners with beauty and personal care brands. Its product categories include skincare, make up, hair, fragrance and wellness. Its skin care products include cosmeceuticals, serums and treatments, moisturizers, cleansers, exfoliators and masks. The firm's makeup products include foundation, concealer, global shades, primer, powder, setting spray, blush and highlighters. The firm's hair products include shampoo, conditioner, scalp scrubs, dry shampoo, treatments, hair color, hair supplements, hairbrushes and tools, hair accessories, hair concern and blonde hair. Its fragrance products include home fragrance, the scent room, and fragranced hand and body care. The firm's wellness products include face sculpting tool, face roller, face mask, tongue cleaner and eye mask.

📊 Share price

$1.06 AUD

NULL AUSTRALIA

NULL TECH

NULL CONSUMER

Want more shares? Try these...

Energy One Ltd. engages in the development and provision of software solutions to the electricity and gas sector. The company is headquartered in North Sydney, New South Wales. The company went IPO on 2007-01-15. The firm's products include NemSight, EOT, SimEnergy, EnergyFlow, EnergyOffer, pypIT, enTrader, envoy, enPrice, eZ-Ops, egssPort Gas, egssPort Power, and Cosmos. NemSight is its windows-based real time presentation and historical analysis tool for Australian electricity, gas, and renewables markets. EOT is its front, middle and back-office solution for electricity, environmental, carbon, gas, oil and other energy commodities for Australia, Singapore, and the Philippines. SimEnergy is its packaged energy trading and risk management (ETRM) solution. EnergyFlow is a platform for automating and managing business processes and for integrating systems. The company provides product solutions for energy market analytics; ETRM-contracts trading, settlements and risk; electricity, and gas bidding, scheduling and nomination; and process automation and integration.

📊 Share price

$2.95 AUD
Compare
Add to watchlist